CRAVES FRED B
SEC CIK 1014095 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir, 10% | 356.2K | — | $12.20M | 14 | 2021-12-03 | 2025-03-12 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
CRAVES FRED B made no open-market trades at MDGL in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-14 | 2025-03-12+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | S - Sale+OE | $328.54 | -15.5K | 356.2K | -4% | -$5.08M |
| DM | 2025-03-14 | 2025-03-12+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | M - OptEx | $82.90 | +15.5K | 351.8K | +5% | +$1.28M |
| MI | 2024-12-05 | 2024-12-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | S - Sale | $315.31 | -3,600 | 11.5K | -24% | -$1.14M |
| MI | 2024-11-27 | 2024-11-25 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | S - Sale | $350.30 | -3,400 | 15.8K | -18% | -$1.19M |
| 2024-09-17 | 2024-09-13 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | G - Gift | $0.00 | -15.0K | 360.1K | -4% | $0 | |
| D | 2024-06-27 | 2024-06-25 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | A - Grant | $0.00 | +714 | 375.1K | +0.2% | $0 |
| 2024-06-13 | 2024-06-11 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | G - Gift | $0.00 | -39.0K | 374.4K | -9% | $0 | |
| I | 2024-06-13 | 2024-06-11 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | G - Gift | $0.00 | -45.9K | 11.2K | -80% | $0 |
| DMT | 2024-05-16 | 2024-05-14 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | M - OptEx | $103.02 | +22.5K | 435.9K | +5% | +$2.32M |
| DMT | 2024-05-16 | 2024-05-14 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | S - Sale+OE | $212.87 | -22.5K | 418.5K | -5% | -$4.79M |
| MI | 2023-12-11 | 2023-12-07 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | J - Other | $0.00 | -1.56M | 0 | -100% | $0 |
| I | 2023-12-11 | 2023-01-30 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | G - Gift | $0.00 | -3,557 | 57.1K | -6% | $0 |
| 2023-06-20 | 2023-06-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir | A - Grant | $0.00 | +1,198 | 362.6K | +0.3% | $0 | |
| MI | 2021-12-07 | 2021-12-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Dir, 10% | J - Other | $0.00 | -824.2K | 1.51M | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations